Lifesciences

Rediff.com » News » Lifesciences

News for Lifesciences

News
Business

How companies show electoral donations in annual reports

A reading of the reports suggests that there is no standard practice for reporting political contributions and it is left to the company's discretion to report them as they find fit. Illustration:......

Nuclear emergency drug developed with DRDO tech gets approval

A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on......

Coming Soon, New Ways To Vaccinate

'Just put a patch on your arm and the vaccine can be absorbed by the body.' IMAGE: Administering vaccines through the oral and nasal route are also likely to gain popularity over the traditional......

Zydus Cadila starts supply of COVID-19 vaccine to govt

Drug firm Zydus Cadila on Wednesday said it has commenced supplies of its COVID-19 vaccine ZyCoV-D to the central government. Photograph: Kind courtesy Zydus Cadila The company has initiated the......

If no new variant, 3rd Covid wave will not be as devastating as 2nd, says Kang

There will not be a third wave of Covid of the size and consequence the country witnessed during the second wave unless there is a new variant of coronavirus, top vaccinologist Gagandeep Kang said......

Zydus gets China nod for kidney disease drug

Ahmedabad-based Zydus Lifesciences said on Tuesday that a new drug application for its oral drug Desidustat used in treating anaemia in chronic kidney disease (CKD) patients had been accepted by......

Q3 result preview: US, India to aid revenue growth for Pharma Inc

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for......

India's pharma industry likely to take 5-6% price hikes this year

Notwithstanding the fact that the country’s pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential......

ACC, HDFC AMC, 3 others to be excluded from Nifty Next 50

Five firms, including ACC Ltd, HDFC Asset Management Company and FSN E-Commerce Ventures that runs Nykaa, will be dropped from Nifty Next 50 index from September 29. Photograph: Danish......

US drug shortage, stable pricing set to boost pharma revenues

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India’s pharmaceutical companies during the first quarter of this financial......

Rediff News

Lifesciences

News for Lifesciences

How companies show electoral donations in annual reports

Nuclear emergency drug developed with DRDO tech gets approval

Coming Soon, New Ways To Vaccinate

Zydus Cadila starts supply of COVID-19 vaccine to govt

If no new variant, 3rd Covid wave will not be as devastating as 2nd, says Kang

Zydus gets China nod for kidney disease drug

Q3 result preview: US, India to aid revenue growth for Pharma Inc

India's pharma industry likely to take 5-6% price hikes this year

ACC, HDFC AMC, 3 others to be excluded from Nifty Next 50

US drug shortage, stable pricing set to boost pharma revenues

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS